Phase 3 Huntington Disease Clinical Trials
3 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–3 of 3 trials
Recruiting
Phase 3
A Study to Investigate the Efficacy, Safety and Tolerability of Votoplam in Participants With Huntington's Disease
Huntington Disease
Novartis Pharmaceuticals770 enrolled10 locationsNCT07326709
Recruiting
Phase 2Phase 3
Study of SKY-0515 for Safety, Efficacy, and Pharmacodynamics in Participants With Huntington's Disease
Huntington DiseaseHuntingtons Disease
Skyhawk Therapeutics, Inc.120 enrolled12 locationsNCT06873334
Recruiting
Phase 2Phase 3
Study to Evaluate the Pharmacodynamics, Safety and Efficacy of SKY-0515 in Participants With Huntington's Disease
Huntington Disease
Skyhawk Therapeutics, Inc.400 enrolled4 locationsNCT07378644